The Delta Electronics-backed company, which has developed an artificial heart for transplants, has filed for a $40m initial public offering on Nasdaq.

The ProSiebenSat.1 and Access Industries-backed music streaming service is considering another equity round or an initial public offering to raise more cash.

The Celgene and Sorrento-backed immunotherapy drug developer initially raised $207m when it floated on Nasdaq last week.

Celgene will invest $17m in the immuno-oncology company, also backed by Sorrento, as it floats in the largest biotech initial public offering ever.

Jupai, a China-based wealth management and advisory service backed by Sina and E-House, will float on the New York Stock Exchange later today.

The MedImmune-backed rare disease drug developer initially raised $60m when it went public on Nasdaq last week.

The business management software provider, which received early investment from Cisco and Berteslmann, had raised $57m in funding prior to the initial public offering.

The Ping An-backed holding company, which oversees three investment units, raised $1.96bn in an initial public offering that will fund strategic expansion.

The biotechnology company previously raised more than $100m from investors including Medimmune, a subsidiary of pharmaceutical company AstraZeneca.